Project Grant R01HL180303
Award Date 7/25/26
Completion Date 3/31/31
Dollars Obligated $760K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Piscataway, NJ 08854, USA
Similar Awards
- The National Heart, Lung, and Blood Institute awarded Rutgers, The State University of New Jersey (RBHS-School of Nursing) $554,766 on June 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate mechanisms underlying susceptibility to ozone-induced acute respiratory distress syndrome. The research focuses on why only some patients with sepsis develop acute respiratory distress syndrome and how exposure to air pollutants such as ozone exacerbates this...
- The National Heart, Lung, and Blood Institute awarded Rutgers The State University of New Jersey $631,413 on August 1, 2026, as a Project Grant (R01HL183945) under the Cardiovascular Diseases Research program (CFDA 93.837). The award funds research investigating the role of lipotoxicity-induced splenic cell alternative splicing in obesity cardiomyopathy. The study examines how fatty acid-induced alternative splicing of the BCL2L1 gene in the spleen contributes to the development of obesity...
- The National Heart, Lung, and Blood Institute awarded $742,459 to Rutgers The State University of New Jersey, doing business as RBHS-School of Nursing, on August 15, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837). The recipient is conducting a comprehensive epidemiologic study evaluating treatment optimization among people with cystic fibrosis in the era of highly effective modulator therapy. The study leverages the Cystic Fibrosis Foundation Patient Registry linked to...
- The National Heart, Lung, and Blood Institute awarded $1.555 million to the University of Maryland, Baltimore on August 5, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to model and treat chronic HIV-induced lung infections. The research investigates immune mechanisms underlying increased susceptibility to respiratory infections in people living with HIV. The project focuses on how chronic HIV infection impairs dendritic cell differentiation and function, hypothesizing...
- The National Institute of Allergy and Infectious Diseases awarded Rutgers The State University of New Jersey (doing business as RBHS-School of Nursing) $764,590 on February 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate the ontogeny and functions of trained macrophages in type 2 immunity. The research addresses helminth parasite infections affecting an estimated 2 billion people globally and examines how type 2 inflammatory responses balance...
- The National Institute of Allergy and Infectious Diseases awarded Rutgers The State University of New Jersey $431,750 on September 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to define the impact of phosphatidylserine-targeting antibodies on T cell function in HIV-1 infection. The research investigates how phosphatidylserine-reactive antibodies, produced endogenously during HIV-1 infection, influence T cell dysregulation and immune activation in people...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded Rutgers The State University of New Jersey a $721,720 Project Grant effective September 1, 2025, through July 31, 2029, under the Cardiovascular Diseases Research program (CFDA 93.837). This research initiative investigates the psychosocial and cultural determinants of cardiometabolic health among older foreign-born Chinese Americans, an understudied population disproportionately affected by...
- The National Institute of Allergy and Infectious Diseases awarded Rutgers The State University of New Jersey $647,356 on June 17, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate the role of GPR132 in regulating CD8 T cell responses during infection and cancer. The research aims to determine how GPR132, a G protein–coupled receptor that detects oxidized endogenous and microbial lipids, regulates CD8 T cell expansion and memory differentiation. The...
- Federal Grant Award Summary Rutgers The State University of New Jersey, School of Nursing, received a $416,121 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) on June 11, 2025, with a completion date of May 31, 2027. This award supports investigator-initiated biomedical research examining the role of TBet+ B cells in viral reinfection and host protection. The research will advance...
- The National Heart, Lung, and Blood Institute awarded Rutgers The State University of New Jersey, School of Nursing, $117,750 on May 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct proteomic profiling and neurocognitive assessment to uncover stroke mechanisms in adults with sickle cell disease. The study quantifies neurodegeneration-associated and mitochondrial proteins in a cohort of 90 sex- and age-matched adults comprising 30 healthy controls, 30...